Mirae Asset Healthcare Fund - Direct Plan - Growth

  • Scheme Category:  
  • Equity Scheme >  
NAV: ₹ 52.119 ↓ -0.96%
[as on 1 September, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Mirae Asset Healthcare Fund - Direct Plan - Growth and its peers as on 1 September, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Mirae Asset Healthcare Fund - Direct Plan - Growth 21.91% -0.96% 0.63% 1.13% 11.46% 22.39% 23.87% 15.78% 25.86%-
Nippon India Consumption Fund - Direct Plan Growth Plan - Growth Option -1.34% -0.74% -2.51% -1.54% 9.21% -3.52% 10.66% 13.34% 18.96% 13.47%
Nippon India Japan Equity Fund- Direct Plan- Growth Plan- Growth Option 25.55% -0.56% 0.08% 2.66% 3.08% 30.78% 21.37% 11.61% 13.23% 11.62%
Nippon India US Equity Opportunities Fund- Direct Plan- Growth Plan- Growth Option 11.8% -1.54% -1.82% 2.37% 4.92% 17.77% 19.14% 12.16% 16.04% 16.19%
Nippon India Taiwan Equity Fund- Direct Plan- Growth Option 99.94% 2.42% 7.41% 23% -5% 138.81% 61.5%---
Nippon India Active Momentum Fund-Direct Plan - Growth Option 9.06% -0.92% -1.29% 1.03% 9.82% 15.04%----

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns--- 8.32% 77.37% 27.95% -10.87% 36.86% 41.36% -2.65%

Discrete returns (monthly)

MonthNov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026
Returns -0.38% -0.71% -5.19% 7.4% -3.5% 6.96% 3.31% 5.37% 5.1% 2.11%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 16.3% 10.32%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.74% 0.01% (Arbitrage: 0.00%) 0.00% 0.00% 1.25%

Equity

NameSymbol / ISINSectorWeight %Other links
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology11.06%
Divi's Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.71%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology7.47%
Apollo Hospitals Enterprise Ltd.APOLLOHOSP (INE437A01024)Healthcare Services5.94%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology5.53%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology5.13%
Aurobindo Pharma Ltd.AUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.82%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology3.56%
Fortis Healthcare Ltd.FORTIS (INE061F01013)Healthcare Services3.55%
Krishna Institute of Medical Sciences Ltd.KIMS (INE967H01025)Healthcare Services3.48%
Dr. Reddy's Laboratories Ltd.DRREDDY (INE089A01031)Pharmaceuticals & Biotechnology3.46%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology3.27%
Onesource Specialty Pharma Ltd.ONESOURCE (INE013P01021)Pharmaceuticals & Biotechnology3.23%
Sai Life Sciences Ltd.SAILIFE (INE570L01029)Pharmaceuticals & Biotechnology3.17%
Aster DM Quality Care Ltd.ASTERDM (INE914M01019)Healthcare Services3.14%
IPCA Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology3.13%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals & Biotechnology3.03%
Eris Lifesciences Ltd.ERIS (INE406M01024)Pharmaceuticals & Biotechnology2.82%
Dr. Lal Path labs Ltd.LALPATHLAB (INE600L01024)Healthcare Services2.81%
Max Healthcare Institute Ltd.MAXHEALTH (INE027H01010)Healthcare Services2.81%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology2.11%
Biocon Ltd.BIOCON (INE376G01013)Pharmaceuticals & Biotechnology2.08%
Mankind Pharma Ltd.MANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.04%
Narayana Hrudayalaya Ltd.NH (INE410P01011)Healthcare Services1.19%
Anthem Biosciences Ltd.ANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology1.15%
Neogen Chemicals Ltd.NEOGEN (INE136S01016)Chemicals & Petrochemicals0.61%
Deepak Nitrite Ltd.DEEPAKNTR (INE288B01029)Chemicals & Petrochemicals0.44%

Debt

NameRatingWeight %
Mirae Asset Liquid Fund-Direct Plan-Growth0.01%
Portfolio data is as on date 31 July, 2026

NAV history

Mirae Asset Healthcare Fund - Direct Plan - Growth - 30 days NAV (Net asset value) history

DateNAV% change
1 September, 202652.119 -0.96%
31 August, 202652.625 0.47%
28 August, 202652.380 0.42%
27 August, 202652.159 0.56%
26 August, 202651.867 0.14%
25 August, 202651.792 1.04%
24 August, 202651.259 0%
21 August, 202651.259 -0.25%
20 August, 202651.386 0.22%
19 August, 202651.274 -0.64%
18 August, 202651.602 0.36%
17 August, 202651.418 -0.1%
14 August, 202651.468 -0.45%
13 August, 202651.702 0.09%
12 August, 202651.653 -0.6%
11 August, 202651.966 0.53%
10 August, 202651.690 -0.03%
7 August, 202651.708 0.2%
6 August, 202651.607 0.08%
5 August, 202651.568 0.12%
4 August, 202651.507 -0.27%
3 August, 202651.648 0.22%
31 July, 202651.537 0.42%
30 July, 202651.320 -0.33%
29 July, 202651.489 1.38%
28 July, 202650.789 0.14%
27 July, 202650.717 1.57%
24 July, 202649.932 -0.14%
23 July, 202650.003 -0.54%
22 July, 202650.273

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Mirae Asset Healthcare Fund - Direct Plan - Growth?
    The latest NAV of Mirae Asset Healthcare Fund - Direct Plan - Growth is 52.119 as on 1 September, 2026.
  • What are YTD (year to date) returns of Mirae Asset Healthcare Fund - Direct Plan - Growth?
    The YTD (year to date) returns of Mirae Asset Healthcare Fund - Direct Plan - Growth are 21.91% as on 1 September, 2026.
  • What are 1 year returns of Mirae Asset Healthcare Fund - Direct Plan - Growth?
    The 1 year returns of Mirae Asset Healthcare Fund - Direct Plan - Growth are 22.39% as on 1 September, 2026.
  • What are 3 year CAGR returns of Mirae Asset Healthcare Fund - Direct Plan - Growth?
    The 3 year annualized returns (CAGR) of Mirae Asset Healthcare Fund - Direct Plan - Growth are 23.87% as on 1 September, 2026.
  • What are 5 year CAGR returns of Mirae Asset Healthcare Fund - Direct Plan - Growth?
    The 5 year annualized returns (CAGR) of Mirae Asset Healthcare Fund - Direct Plan - Growth are 15.78% as on 1 September, 2026.
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Mirae Asset Healthcare Fund - Direct Plan - Growth?
    Mirae Asset Healthcare Fund - Direct Plan - Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.